AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2017

Aug 30, 2017

30870_dirs_2017-08-30_3993e45d-a3de-41c5-9176-5fc146a1503c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-08-29

Reporting Person: COSTA SANTO J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-29	Common Stock	M	5000	$4.44	Acquired	5000	Direct
2017-08-29	Common Stock	S	5000	$14.0	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-29	Non-Qualified Stock Option (right to buy)	$4.44	M	5000	Disposed	2024-05-21	Common Stock (5000)	Direct

Footnotes

F1: The exercise(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2017.

F2: The sale(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2017.